Bashir, Naazish S.
Walters, Thomas D.
Griffiths, Anne M.
Otley, Anthony
Critch, Jeff
Ungar, Wendy J. http://orcid.org/0000-0002-0762-0101
Funding for this research was provided by:
Canadian Institutes of Health Research (137137, 297862)
Sickkids Research Institute (RestraComp Post-doctoral fellowship)
Canada Excellence Research Chairs, Government of Canada
CH.I.L.D. Foundation
Article History
Accepted: 19 March 2023
First Online: 1 April 2023
Declarations
:
: Naazish Bashir and Wendy Ungar declare they have no conflicts of interest. Thomas Walters has served on advisory boards for AbbVie and Janssen, received research support from AbbVie, and participated in speaker’s bureaus for AbbVie, Janssen, and Nestle Health Sciences. Anne Griffiths has been a consultant for Abbvie, Amgen, Bristol Myers Squibb, Janssen, Lilly and Merck and has received speaker fees from Abbvie, Janssen, and Nestle, and research support from Abbvie. Anthony Otley has been a consultant for AbbVie, an advisory board member for AbbVie and Janssen, and has received research support from AbbVie, Lilly, Takeda and Janssen. Jeff Critch has been a consultant for Abbvie and Pharma Science.
: The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study was approved by the Research Ethics Boards of the Hospital for Sick Children in Toronto, ON (#1000039604), the IWK Health Centre in Halifax, NS (#1015558), and the Janeway Children's Health and Rehabilitation Centre in St. John’s NL (#13.229). All parent participants provided informed consent and children provided informed assent.